Becton Dickinson to Pay $175 Million for Misleading Investors …

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

sec.gov

$175
OFF

BD To Pay $175M To Settle Charges Of Misleading Investors On …

3 weeks from now

Dec 17, 2024 · Dive Brief: BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with …

medtechdive.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 16, 2024 · Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and …

nasdaq.com

$175
OFF

Becton, Dickinson To Pay $175M To Settle Claims Over Misleading …

3 weeks from now

The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued …

msn.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 17, 2024 · * New Jersey-based company will also retain independent compliance consultant. Washington D.C. - The Securities and Exchange Commission today announced settled …

marketscreener.com

$175
OFF

BD Resolves Previously Disclosed SEC Investigation

3 weeks from now

Dec 16, 2024 · As part of the settlement, BD has agreed to pay $175 million to the SEC, an amount that was reserved and disclosed in the company's fiscal year 2024 Form 10-K and …

bd.com

$175
OFF

Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 …

3 weeks from now

Dec 21, 2024 · The Securities and Exchange Commission on Monday announced it had settled charges against Becton, Dickinson and Company BDX, known as BD, for repeatedly …

benzinga.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

BD agreed to pay a $175 million civil penalty. According to the SEC's order, BD determined in 2016 that software changes made to the Alaris pump required regulatory clearance from the …

marketwatch.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 16, 2024 · Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump December 16, 2024 4:38 PM EST | Source: Newsfile SEC Press Digest …

newsfilecorp.com

$175
OFF

BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System ...

3 weeks from now

Dec 17, 2024 · (RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and …

businessinsider.com

$175
OFF

BD Pays $175M To Settle SEC Claims It Failed To Report Infusion …

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission (SEC) today announced settled charges against Becton, Dickinson and Company (BD), a New Jersey-based medical device …

medicaldesigndevelopment.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors On …

3 weeks from now

Dec 16, 2024 · Becton, Dickinson and Company (BD), a New Jersey-based medical device manufacturer, has agreed to pay a $175 million civil penalty to the Securities and Exchange …

grcreport.com

$175
OFF

Becton Dickinson Pays $175M For Misleading Investors About …

3 weeks from now

Dec 18, 2024 · Becton Dickinson (BD) medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew …

complianceweek.com

$175
OFF

Becton Dickinson To Pay $175 Million Fine Related To SEC …

3 weeks from now

Dec 16, 2024 · Becton Dickinson has agreed to pay a $175 million fine to settle an investigation by the U.S. Securities and Exchange Commission. The previously disclosed investigation was …

morningstar.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump <hr> SEC Charges Express, Inc. with Failing to Disclose Nearly $1 Million in Perks Provided to …

seclaw.com

$175
OFF

Becton Dickinson To Pay $175 Million To Settle SEC Investigation …

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as …

jeffnewmanlaw.com

$175
OFF

Becton Dickinson's $175 Million Lesson: Misleading Investors

3 weeks from now

Dec 17, 2024 · The U.S. Securities and Exchange Commission announced that Becton, Dickinson and Company will pay a $175 million civil penalty for misleading investors about the risks …

linkedin.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 16, 2024 · Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and …

stockhouse.com

FAQs about Becton Dickinson to Pay $175 Million for Misleading Investors … Coupon?

What happened to Becton Dickinson & Company?

1906: Partnership is incorporated as Becton, Dickinson & Company; factory is built in East Rutherford, New Jersey. 1913: Surgical Supply Import Company is acquired. 1917: Sales reach $1 million. 1918: Company introduces the ACE bandage. 1921: Company acquires Physicians Specialty Company. ...

Why did BD pay $175 million to the SEC?

(RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and Exchange Commission to resolve an investigation concerning past public disclosures and SEC reporting related to the BD Alaris System. ...

How does Becton Dickinson sell its products?

Becton Dickinson uses a hybrid sales distribution model. Its products are marketed and sold in the United States and internationally through independent distribution channels, as well as directly to end-users by Becton Dickinson sales representatives. Becton Dickinson’s domestic sales team sells primarily to distributors. ...

Why did the SEC settle charges against BD?

The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. ...

How does Becton Dickinson make money?

Becton Dickinson makes money through the development and sale of medical devices, instrument systems and reagents. The Company also generates revenue through the lease of medical equipment, which is recorded either as operating leases or sales-type leases. ...

Who is the CEO of Becton Dickinson?

Forlenza has been the CEO of Becton Dickinson since [year]. Before that, he served as the company's Chief Operating Officer from 2010. Forlenza holds a bachelor’s degree in Chemical Engineering from Lehigh University and a master’s in Business Administration from Wharton Graduate School, University of Pennsylvania. ...